The UCL academics are among 54 health and biomedical scientists elected to the academy this year, joining a fellowship of 1,450 researchers whose work for the academy includes nurturing the next generation of scientists and shaping research and health policy in the UK and worldwide.

The expertise of Fellows elected spans a wide range of clinical and non-clinical disciplines, from infectious disease and stem cell biology to veterinary medicine and dementia research.

Professor Andrew Morris, President of the Academy of Medical Sciences, said: “It is a privilege to welcome these 54 exceptional scientists to our Fellowship. Each new Fellow brings unique expertise and perspective to addressing the most significant health challenges facing society. 

“The breadth of disciplines represented in this year’s cohort – from mental health and infectious disease to cancer biology and respiratory medicine – reflects the rich diversity of medical science today. Their election comes at a crucial time when scientific excellence and collaboration across disciplines are essential for addressing global health challenges both now and in the future. We look forward to working with them to advance biomedical research and create an environment where the best science can flourish for the benefit of people everywhere.” 

The new Fellows will be formally admitted to the Academy at a ceremony on Wednesday 9 July 2025.

The academics from UCL Queen Square Institute of Neurology are:

  • Professor Rickie Patani, Professor of Human Stem Cells and Regenerative Neurology, Department of Neuromuscular Diseases
  • Professor Jonathan Schott, Professor of Neurology, Neurodegenerative Diseases
  • Professor David Werring, Professor of Clinical Neurology, Department of Translational Neuroscience and Stroke

Links